EnglishJapaness Traditional Chinese Simplified Chinese
Ȩ > ±Û·Î¹úÆÄÆ®³Ê > Global Markets Direct

Global Markets Direct

Globla Market Direct ¸®¼­Ä¡»ç´Â ÀÚü µ¥ÀÌÅÍ ¿Í ´Ù¾çÇÑ ¸®¼­Ä¡ ±â¹ýÀ» ÀÌ¿ëÇÏ¿© ±â¾÷ °æÀï·Â À¯Áö¿¡ ÇʼöÀûÀÎ ½Å·Ú¼º ³ôÀº ÃֽŠÁ¤º¸¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. °æÀï»ç ºÐ¼®ºÎÅÍ À繫Àü·«, °í°´ ºÐ¼®¿¡ À̸£±â ±îÁö ¸®¼­Ä¡ Àü¹®°¡°¡ Àü¼¼°è Áö¿ª¿¡ ´ëÇÑ Á¶»ç¸¦ ¼öÇàÇϰí ÀÖ½À´Ï´Ù.
°Ë»ö
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 1251 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195276
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
34 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195277
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
44 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195278
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
30 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195279
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
69 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195280
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
44 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195281
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
121 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195282
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
200 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195283
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
216 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195284
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
60 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195285
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
94 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195286
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
36 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195287
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
30 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195288
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
59 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195289
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
35 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195290
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
54 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195291
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
37 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195292
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
54 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195293
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
60 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195294
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
50 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195295
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
1560 Pages
°¡°Ý
US $ 2,500 -> £Ü 3,246,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195296
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
1182 Pages
°¡°Ý
US $ 2,500 -> £Ü 3,246,000
¿­¶÷¼­ºñ½º
Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195297
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
143 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195298
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
1036 Pages
°¡°Ý
US $ 2,500 -> £Ü 3,246,000
¿­¶÷¼­ºñ½º
Recurrent Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195299
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
45 Pages
°¡°Ý
US $ 2,000 -> £Ü 2,596,000
¿­¶÷¼­ºñ½º
Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
¸®¼­Ä¡»ç
Global Markets Direct
»óǰÄÚµå
1195300
¹ßÇàÀÏ
2022³â 12¿ù
ÆäÀÌÁö Á¤º¸
507 Pages
°¡°Ý
US $ 2,500 -> £Ü 3,246,000
¿­¶÷¼­ºñ½º

»ó±â ÀÚ·á ÀÌ¿ÜÀÇ Global Markets Direct ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦